|Articles|October 1, 2001
Laser, Drug Benefits Equal for IOP
NEW YORK-Laser iridotomy appears to work equally as well as traditional medical management in patients with pigment dispersion syndrome (PDS), according to glaucoma researchers here.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
First patient treated in ViaLase’s IDE trial
2
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
3
Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007
4
Inflammasome Therapeutics completes phase 2 trial enrollment for K8 in GA
5











































.png)


